PP2A Is Required for B Cell Survival and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

被引：4

作者：

Gang, Xiao ^{[1
]}

Geng, Huimin ^{[2
]}

Chan, Lai N. ^{[1
]}

Chen, Zhengshan ^{[1
]}

Jiang, Xiaoyan ^{[3
]}

Muschen, Markus ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Lab Med, San Francisco, CA 94143 USA

[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

10.1182/blood.V126.23.3900.3900

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] EXPRESSION OF ANNEXIN 2 IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA B: A MARKER OF AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
Tumino, M.
Accordi, B.
Sciro, M.
Milani, G.
Tognazzo, F.
Giordan, M.
te Kronnie, G.
Lo Nigro, L.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S45 - S45
[22] Mitochondrial PP2A may contribute to the chemosensitivity of acute lymphoblastic leukemia derived REH cells.
Ruvolo, PP
Deng, XM
May, WS
BLOOD, 1999, 94 (10) : 67A - 67A
[23] Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia
Miyoung Lee
Jamie A. G. Hamilton
Ganesh R. Talekar
Anthony J. Ross
Langston Michael
Manali Rupji
Bhakti Dwivedi
Sunil S. Raikar
Jeremy Boss
Christopher D. Scharer
Douglas K. Graham
Deborah DeRyckere
Christopher C. Porter
Curtis J. Henry
Nature Communications, 13
[24] Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia
Lee, Miyoung
Hamilton, Jamie A. G.
Talekar, Ganesh R.
Ross, Anthony J.
Michael, Langston
Rupji, Manali
Dwivedi, Bhakti
Raikar, Sunil S.
Boss, Jeremy
Scharer, Christopher D.
Graham, Douglas K.
DeRyckere, Deborah
Porter, Christopher C.
Henry, Curtis J.
NATURE COMMUNICATIONS, 2022, 13 (01)
[25] Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia
Chen, Zhenhua
Zhou, Keren
Xue, Jianhuang
Small, Andrew
Xiao, Gang
Nguyen, Le Xuan Truong
Zhang, Zheng
Prince, Emily
Weng, Hengyou
Huang, Huilin
Zhao, Zhicong
Qing, Ying
Shen, Chao
Li, Wei
Han, Li
Tan, Brandon
Su, Rui
Qin, Hanjun
Li, Yangchan
Wu, Dong
Gu, Zhaohui
Ngo, Vu N.
He, Xin
Chao, Jianfel
Leung, Keith
Wang, Kitty
Dong, Lei
Qin, Xi
Cal, Zhenming
Sheng, Yue
Chen, Yu
Wu, Xiwei
Zhang, Bin
Shi, Yanhong
Marcucci, Guido
Qian, Zhijian
Xu, Mingjiang
Muschen, Markus
Chen, Jianjun
Deng, Xiaolan
SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (689)
[26] TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia
Bensberg, Maike
Rundquist, Olof
Selimovic, Aida
Lagerwall, Cathrine
Benson, Mikael
Gustafsson, Mika
Vogt, Hartmut
Lentini, Antonio
Nestor, Colm E.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (34)
[27] Zhx2 promotes survival of B-cell acute lymphoblastic leukemia cell lines
Sharma, Namit
Hou, Huayun
Wilson, Michael D.
McGlade, Catherine Jane
CANCER RESEARCH, 2016, 76
[28] MDMX is widely expressed in adult pre-cursor B cell B acute lymphoblastic leukemia and is a potential therapeutic target
Han, X
Garcia-Manero, G
McDonnell, T
Lozano, G
Medeiros, LJ
Rosner, G
Hayes, KJ
Bueso-Ramos, CE
BLOOD, 2005, 106 (11) : 917A - 917A
[29] PDGFR-β As a New Therapeutic Target in T-Cell Acute Lymphoblastic Leukemia
De Coninck, Stien
De Smedt, Renate
Lintermans, Beatrice
Goossens, Steven
Van Vlierberghe, Pieter
BLOOD, 2022, 140 : 11513 - 11514
[30] Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia
Shirazi, Paniz Tavakoli
Eadie, Laura N.
Heatley, Susan L.
Page, Elyse C.
Francois, Maxime
Hughes, Timothy P.
Yeung, David
White, Deborah L.
CANCER GENE THERAPY, 2022, 29 (8-9) : 1140 - 1152

← 1 2 3 4 5 →